DANBURY, Conn.--(BUSINESS WIRE)--IMS Health (NYSE:IMS) today announced that the company has received approval from the European Commission in connection with the pending acquisition of certain Cegedim information solutions and customer relationship management (CRM) businesses. In addition to the Commission’s approval, the waiting period for the U.S. antitrust review under the Hart-Scott-Rodino Antitrust Improvements Act (HSR) expired on December 5, 2014. Accordingly, all of the material regulat
| < Prev | Next > |
|---|
